Cargando…
Assessment of Perceived Barriers to Herpes Zoster Vaccination among Geriatric Primary Care Providers
The herpes zoster vaccine is recommended for use in adults 60 years of age and older to reduce the incidence and morbidity associated with infection. Its limited uptake has been attributed to logistical barriers, but uncertain efficacy and safety in subsets of this patient population could also be c...
Autores principales: | Montag Schafer, Katherine, Reidt, Shannon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419371/ https://www.ncbi.nlm.nih.gov/pubmed/28970403 http://dx.doi.org/10.3390/pharmacy4040030 |
Ejemplares similares
-
Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013) -
Herpes Zoster Vaccines
por: Harbecke, Ruth, et al.
Publicado: (2021) -
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
por: Yih, W Katherine, et al.
Publicado: (2022) -
Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017) -
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
por: Marra, Yasmin, et al.
Publicado: (2022)